Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils
Ss. Visser et al., Apparent involvement of the A(2A) subtype adenosine receptor in the anti-inflammatory interactions of CGS 21680, cyclopentyladenosine, and IB-MECA with human neutrophils, BIOCH PHARM, 60(7), 2000, pp. 993-999
This study was undertaken to identify the adenosine receptor (AR) subtypes
which downregulate the proinflammatory activities of human neutrophils, as
well as the involvement of adenosine 3',5'-cyclic monophosphate (cAMP) and
its relationship to cellular handling of Ca2+ in mediating these effects. N
eutrophils were treated with varying concentrations (0.01-1 mu M) of AR ago
nists operative at A(1) (N-6-cyclopencyladenosine, CPA), A(2A) (2(4-[(2-car
boxyethyl)phenyl]ethylamino)-5'-N-ethylcarboxamidoadenosine, CGS 21680), an
d A(3) (N-6-(3-iodobenzyl-5)-N-methylcarbamoyladenosine, IB-MECA) receptors
, after which they were activated with the chemoattractant, N-formyl-L-meth
ionyl-L-leucyl-L-phenylalanine (FMLP, 1 mu M). Intracellular cAMP, superoxi
de, and elastase were assayed using radioimmunoassay, lucigenin-enhanced ch
emiluminescence (LECL), and colorimetric procedures, respectively, while ch
anges in the concentrations of cytosolic Ca2+ were monitored by fura-2-base
d spectrofluorimetry. CGS 21680, at all concentrations tested, inhibited su
peroxide production in a dose-related manner, while CPA and IB-MECA were ef
fective only at the highest concentrations tested (0.5-1 mu M). The release
of elastase from activated neutrophils was also inhibited by all three AR
agonists, but was more sensitive to CGS 21680 and IB-MECA than was superoxi
de production. The inhibitory effects of all 3 agonists on superoxide produ
ction and elastase release were associated with accelerated clearance of Ca
2+ from the cytosol of activated neutrophils, and were effectively neutrali
zed by pretreatment of the cells with the highly selective A(2A)R antagonis
t, ZM 241385 (4-(2-[7-amino-2-(2-furyl)[1,2,4]triazolo[2,3-a][1,3,5]triazin
-5yl amino]ethyl)phenol). Increased cAMP was detected in neutrophils treate
d with CGS 21680 and IB-MECA (1 mu M) These data support the involvement of
the A(2A)R subtype in the suppression of superoxide production and degranu
lation by activated human neutrophils, probably by cAMP-mediated alteration
s in Ca2+ handling. BIOCHEM PHARMACOL 60;7:993-999, 2000. (C) 2000 Elsevier
Science Inc.